Scientific Industries (OTCQB:SCND), is a life science tool provider. It designs, manufactures, and markets laboratory equipment, including the world-renowned Vortex-Genie® 2 Mixer and Torbal® balances, and bioprocessing systems under the product name Cell Growth Quantifier and Liquid Injection System. Scientific Industries’ products are generally used and designed for research purposes in laboratories of universities, hospitals, pharmaceutical companies, medical device manufacturers, and pharmacies. To learn more, visit www.scientificindustries.com.
Company profile
Ticker
SCND
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
42217279
Latest filings (excl ownership)
10-K/A
2023 FY
Annual report (amended)
18 Jul 24
424B3
Prospectus supplement
28 Jun 24
EFFECT
Notice of effectiveness
27 Jun 24
S-1/A
IPO registration (amended)
18 Jun 24
8-K
Changes in Registrant's Certifying Accountant
6 Jun 24
S-1/A
IPO registration (amended)
31 May 24
10-Q
2024 Q1
Quarterly report
15 May 24
S-1/A
IPO registration (amended)
2 May 24
DEF 14A
Definitive proxy
15 Apr 24
8-K
Departure of Directors or Certain Officers
15 Apr 24
Latest ownership filings
4
Reginald Averilla
1 Jul 24
4
Christopher T Cox
28 Jun 24
4
Christopher T Cox
28 Jun 24
4
MICHAEL BLECHMAN
27 Jun 24
4
HELENA R SANTOS
27 Jun 24
4
JOHN A MOORE
20 Jun 24
4
JOHN A MOORE
13 Jun 24
3
MICHAEL BLECHMAN
26 Apr 24
SC 13G/A
NORTH RUN CAPITAL, LP
21 Mar 24
SC 13G/A
SATTERFIELD THOMAS A JR
14 Feb 24
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Jun 22 | Jun 21 | Jun 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 351.70 k | 351.70 k | 351.70 k | 351.70 k | 351.70 k | 351.70 k |
Cash burn (monthly) | 148.13 k | 60.64 k | 696.50 k | 740.15 k | 521.70 k | 497.95 k |
Cash used (since last report) | 572.77 k | 234.48 k | 2.69 mm | 2.86 mm | 2.02 mm | 1.93 mm |
Cash remaining | -221.07 k | 117.22 k | -2.34 mm | -2.51 mm | -1.67 mm | -1.57 mm |
Runway (months of cash) | -1.5 | 1.9 | -3.4 | -3.4 | -3.2 | -3.2 |
Institutional ownership, Q3 2023
9.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 953.72 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Veradace Capital Management | 953.72 k | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Jun 24 | John A Moore | Common Stock | Buy | Acquire P | No | No | 1.434 | 9,200 | 13.19 k | 414,590 |
13 Jun 24 | John A Moore | Common Stock | Buy | Acquire P | No | No | 1.527 | 7,100 | 10.84 k | 405,390 |
17 May 24 | Michael Blechman | Options to Purchase Common Stock Common Stock | Grant | Acquire A | No | No | 2.5 | 7,186 | 17.97 k | 32,186 |
17 May 24 | Michael Blechman | Options to Purchase Common Stock Common Stock | Grant | Acquire A | No | No | 1.75 | 25,000 | 43.75 k | 25,000 |
1 Apr 24 | John A Moore | Options to Purchase Common Stock Common Stocck | Grant | Acquire A | No | No | 2.5 | 58,182 | 145.46 k | 351,690 |
1 Apr 24 | Helena R Santos | Options to Purchase Common Stock Common Stock | Grant | Acquire A | No | No | 2.5 | 55,100 | 137.75 k | 289,443 |
Press releases
Scientific Industries to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
23 May 24
Scientific Industries Reports Financial Results for First Quarter of Fiscal Year 2024
16 May 24
Scientific Industries to Host First Quarter 2024 Financial Results Investor Call on May 16, 2024
10 May 24